Health financing

Innovative new financing mechanisms such as The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), The US President's Emergency Plan for AIDS Relief (PEPFAR) and UNITAID have recently been developed to ensure sustainable international financing for HIV/AIDS and other diseases. Based on the realization that it will be impossible for most low- and middle-income countries to fund the response from domestic sources, these new instruments channel substantial amounts of international funding to affected countries. Together, these new mechanisms account for the majority of funding available to countries to combat diseases such as HIV/AIDS, TB and Malaria.

An emphasis on performance-based funding requires that countries develop detailed and accurately costed proposals in order to access funding from the Global Fund and PEPFAR. Recent efforts to better integrate this funding with national planning processes (through the National Strategy Applications (NSA) process of the Global Fund) have also elevated the importance of developing well designed and accurately costed national strategies for HIV/AIDS.

Working with partners, WHO supports countries to prepare accurately costed national strategies and proposals for funding through the Global Fund and other international financing mechanisms. The WHO HIV/AIDS Department works within the UNAIDS ASAP mechanism to support the development of costed national strategies for HIV/AIDS and provides tools and technical support for developing costed proposals. In order to provide better information for decision-making, the WHO HIV/AIDS Department follows developments in international financing of HIV/AIDS programmes, supports policy development and documents best practices in financing the health sector response to HIV/AIDS.